| Last update: 05.12.2025 14:20:56 |
Elevator Pitch | ||||
| 10:14 - 10:14 | Elevator Pitch (Alle Slides im Ordner Elevator Pitch. MASTER ELEVATOR PITCH.pptx und einzelne Präsis) No Speaker assigned to this Slot. | |||
| 10:15 - 10:17 | Introduction / Welcome No Speaker assigned to this Slot. | |||
| 10:15 - 11:00 | Zuerst alle Personen 1 Min Präsi, dann Abstimmung und falls selektiert = 2. Runde à 5 Min Präsi und 2 Min. Diskussion Elevator Pitch, | |||
| 10:17 - 10:18 | Long-Term Efficacy and Safety of Palopegteriparatide Treatment in Adults With Chronic Hypoparathyroidism: 4-Year Results From the Phase 2 PaTH Forward Trial Olivier Bonny, Fribourg | |||
| 10:18 - 10:19 | It is never too late - recovery of kidney function with complement inhibition Jan Bruegger, Horgen | |||
| 10:19 - 10:20 | Metabolic risk after living kidney donation: An analysis of the Swiss Organ Living-Donor Health Registry Deborah Buess, Basel | |||
| 10:20 - 10:21 | Unraveling a mechanism underlying hepatitis E-associated kidney disease: the discovery of HEV ORF2 capsid protein- associated immune complex glomerulonephritis Birgit Helmchen, Zürich | |||
| 10:21 - 10:22 | Two Cases of Hyperacute Rejection After AB0 Incompatible Kidney Transplantation: What Lurks Behind the Titre? Kerstin Hübel, Zürich | |||
| 10:22 - 10:23 | Long-term prediction of renal function decline using diffusion MRI in kidney transplant and CKD patients AurÉlie Huber, Genève | |||
| 10:23 - 10:24 | "Isolated v-lesions" do not show molecular rejection, but in combination with microvascular inflammation, increase the probability of molecular mixed rejection Evelyn Kowarik, Luzern | |||
| 10:24 - 10:25 | Single-Kidney Transplantation with Discarded Partner Kidney vs. Dual Kidney Transplantation: Results from a National Cohort Study Christian Kuhn, St. Gallen | |||
| 10:25 - 10:26 | sodium bicarbonate and volume retention in metabolic acidosis after kidney transplantation - a post hoc analysis Alexander Ritter, St. Gallen | |||
| 10:26 - 10:27 | metabolic safety of long-term citrate therapy in high-risk kidney stone formers Alexander Ritter, St. Gallen | |||
| 10:27 - 10:28 | Prognostic value of proteinuria and kidney function in patients with newly diagnosed multiple myeloma Davide Spica, Aarau | |||
| 10:28 - 10:29 | Donor-derived metatastatic tumor presenting six years after kidney transplantation Unal Tokkuzun, Lugano | |||
| 10:29 - 10:30 | Acute kidney injury after catheter-directed thrombolysis versus thrombo-aspiration by AngioJet in patients with acute lower limb ischaemia Melanie Saul, Lausanne | |||
| 10:30 - 10:31 | Molecular Rejection Signals in Chronic-Active T Cell-Mediated Rejection: Histological Drivers and Potential Outcome Implications Lukas Weidmann, Zürich | |||
| 10:31 - 10:34 | Voting im Saal Elevator Pitch, | |||
| 10:34 - 10:41 | 2. Runde (5 Min. Präsentation / 2 Min. Diskussion) No Speaker assigned to this Slot. | |||
| 10:41 - 10:48 | 2. Runde (5 Min. Präsentation / 2 Min. Diskussion) No Speaker assigned to this Slot. | |||
| 10:48 - 10:55 | 2. Runde (5 Min. Präsentation / 2 Min. Diskussion) No Speaker assigned to this Slot. | |||
| 10:55 - 11:02 | 2. Runde (5 Min. Präsentation / 2 Min. Diskussion) No Speaker assigned to this Slot. | |||
| 11:02 - 11:03 | Farewell / Thank you message No Speaker assigned to this Slot. | |||
SRRQAP | ||||
| 11:29 - 11:29 | SRRQAP No Speaker assigned to this Slot. | |||
| 11:30 - 12:15 | Swiss Dialysis Registry Herr Patrice Ambühl, Zürich | 04.12.25 15:29 | ||